For the Inventor, By the Inventor

Enter assignee name

Neuchâtel, Switzerland

Baxter Biotech Technology Sarl

USPTO Granted Patents = 13

% Expired Patents = 7.7

Forward Citations = 260

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Bruce A Kerwin (5 out of 6 patents)

Antony James Mathews (4 out of 17 patents)

Kiyoshi Nagai (3 out of 13 patents)

4. Douglas L Looker (3 out of 14 patents)

5. David C Anderson (2 out of 45 patents)

6. Stephen J Hoffman (2 out of 11 patents)

7. Spencer J Anthony-Cahill (2 out of 4 patents)

8. Janet K Epp (2 out of 2 patents)

9. Christopher Carl Frye (1 out of 13 patents)

10. Michael J Gerber (1 out of 21 patents)

11. Daniel H Doherty (1 out of 27 patents)

12. Elaine A Best (1 out of 9 patents)

13. John S Olson (1 out of 9 patents)

14. Christopher B Glascock (1 out of 4 patents)

15. Douglas D Lemon (1 out of 4 patents)

13 patents: Sort by Forward Citations

1. 7049406 - Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging (2006-05-23),

2. 6828125 - DNA encoding fused di-alpha globins and use thereof (2004-12-07),

3. 6218513 - Globins containing binding domains (2001-04-17),

4. 6184356 - Production and use of multimeric hemoglobins (2001-02-06),

5. 6171826 - Methods of controlling beta dimer formation in hemoglobin (2001-01-09),

6. 6160098 - Method for control of functionality during cross-linking of hemoglobins (2000-12-12),

7. 6150506 - Modified hemoglobin-like compounds and methods of purifying same (2000-11-21),

8. 6136565 - Methods of reducing the levels of protoporphyrin IX in recombinant (2000-10-24),

9. 6124114 - Hemoglobins with intersubunit dislufide bonds (2000-09-26),

10. 5942488 - Haemoglobin (1999-08-24),

11. 5929031 - Storage stable hemoglobin solutions (1999-07-27),

12. 5914391 - Stabilized compositions containing hemoglobin (1999-06-22),

13. 5907035 - Aqueous two-phase metal affinity partitioning protein purification system (1999-05-25),

Company Overview

Baxter Biotech Technology Sarl, based in Neuchâtel, Switzerland, is a prominent player in the biotechnology sector, focusing on the development and manufacturing of innovative medical solutions. The company specializes in advanced biopharmaceuticals and medical devices, aiming to enhance patient care through cutting-edge technology. With a commitment to research and development, Baxter Biotech is dedicated to addressing complex health challenges and improving therapeutic outcomes across various medical fields.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#14 in Neuchâtel

#878 in Switzerland

#45,039 in the World

Neuchâtel, Switzerland

Baxter Biotech Technology Sarl

Forward Citations = 260

26 inventors:

Bruce A Kerwin (5 out of 6 patents)

Antony James Mathews (4 out of 17 patents)

Kiyoshi Nagai (3 out of 13 patents)

4. Douglas L Looker (3 out of 14 patents)

5. David C Anderson (2 out of 45 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Baxter Biotech Technology Sarl. Retrieved from https://idiyas.com/company/baxter-biotech-technology-sarl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…